Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue

Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene blue use in treating ifosfamide-induced metabol...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Investig Med High Impact Case Rep
Главные авторы: Vakiti, Anusha, Pilla, Ravi, Alhaj Moustafa, Muhamad, Joseph, Jacinth J., Shenoy, Aarthi G.
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2018
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6069036/
https://ncbi.nlm.nih.gov/pubmed/30083561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709618786769
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы